 Charles Robertson
Concepts (507)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microbiota | 43 | 2023 | 648 | 3.860 |
Why?
| | Gastrointestinal Microbiome | 28 | 2023 | 501 | 2.770 |
Why?
| | RNA, Ribosomal, 16S | 44 | 2023 | 485 | 1.750 |
Why?
| | Bacteria | 31 | 2023 | 726 | 1.710 |
Why?
| | Cystic Fibrosis | 12 | 2023 | 955 | 0.980 |
Why?
| | Intestinal Mucosa | 10 | 2020 | 530 | 0.870 |
Why?
| | Feces | 16 | 2023 | 374 | 0.860 |
Why?
| | Otitis Media | 5 | 2023 | 143 | 0.800 |
Why?
| | Intestines | 9 | 2017 | 325 | 0.800 |
Why?
| | Metagenome | 10 | 2019 | 122 | 0.770 |
Why?
| | Rhinitis | 6 | 2020 | 128 | 0.700 |
Why?
| | Biodiversity | 11 | 2020 | 358 | 0.700 |
Why?
| | Water Microbiology | 8 | 2018 | 77 | 0.670 |
Why?
| | Sinusitis | 6 | 2020 | 175 | 0.670 |
Why?
| | Paranasal Sinuses | 5 | 2016 | 66 | 0.600 |
Why?
| | Phylogeny | 13 | 2020 | 794 | 0.580 |
Why?
| | Archaea | 2 | 2008 | 69 | 0.550 |
Why?
| | Air Microbiology | 2 | 2015 | 40 | 0.540 |
Why?
| | Ileum | 4 | 2020 | 90 | 0.530 |
Why?
| | Sequence Analysis, DNA | 14 | 2020 | 728 | 0.520 |
Why?
| | Nasopharynx | 4 | 2022 | 62 | 0.480 |
Why?
| | Breast Feeding | 5 | 2023 | 370 | 0.470 |
Why?
| | RNA, Bacterial | 8 | 2018 | 174 | 0.460 |
Why?
| | Computer Graphics | 1 | 2013 | 41 | 0.440 |
Why?
| | Database Management Systems | 1 | 2013 | 48 | 0.440 |
Why?
| | Railroads | 1 | 2013 | 5 | 0.440 |
Why?
| | User-Computer Interface | 1 | 2013 | 141 | 0.410 |
Why?
| | Aerosols | 1 | 2013 | 151 | 0.400 |
Why?
| | Proton Pump Inhibitors | 3 | 2018 | 96 | 0.390 |
Why?
| | Geologic Sediments | 2 | 2008 | 36 | 0.390 |
Why?
| | Trachea | 4 | 2023 | 223 | 0.380 |
Why?
| | Crohn Disease | 4 | 2020 | 196 | 0.360 |
Why?
| | Colon | 3 | 2023 | 233 | 0.360 |
Why?
| | Fucosyltransferases | 2 | 2022 | 27 | 0.350 |
Why?
| | Lung | 7 | 2021 | 3546 | 0.350 |
Why?
| | Inflammation | 10 | 2022 | 2481 | 0.340 |
Why?
| | Dysbiosis | 5 | 2023 | 145 | 0.340 |
Why?
| | Arthritis, Experimental | 2 | 2023 | 132 | 0.340 |
Why?
| | DNA, Bacterial | 8 | 2021 | 310 | 0.330 |
Why?
| | Software | 1 | 2013 | 536 | 0.330 |
Why?
| | Humans | 75 | 2023 | 114757 | 0.330 |
Why?
| | Genes, rRNA | 5 | 2015 | 39 | 0.310 |
Why?
| | Case-Control Studies | 15 | 2020 | 3005 | 0.310 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2021 | 141 | 0.310 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2022 | 245 | 0.300 |
Why?
| | Male | 49 | 2022 | 55579 | 0.290 |
Why?
| | Female | 50 | 2023 | 59507 | 0.290 |
Why?
| | Sulfolobus solfataricus | 1 | 2007 | 8 | 0.280 |
Why?
| | Bronchoalveolar Lavage Fluid | 4 | 2021 | 589 | 0.280 |
Why?
| | Water Pollutants, Chemical | 2 | 2020 | 175 | 0.280 |
Why?
| | Dietary Supplements | 3 | 2019 | 460 | 0.270 |
Why?
| | Legionella | 2 | 2017 | 7 | 0.270 |
Why?
| | Pseudomonas Infections | 3 | 2023 | 184 | 0.260 |
Why?
| | Fatty Liver | 2 | 2021 | 213 | 0.260 |
Why?
| | Cryoelectron Microscopy | 1 | 2007 | 144 | 0.260 |
Why?
| | Drinking Water | 3 | 2017 | 64 | 0.260 |
Why?
| | Fatty Acids, Volatile | 4 | 2019 | 47 | 0.260 |
Why?
| | Nod2 Signaling Adaptor Protein | 4 | 2019 | 30 | 0.250 |
Why?
| | Molecular Sequence Data | 8 | 2015 | 2791 | 0.250 |
Why?
| | Environmental Microbiology | 1 | 2005 | 43 | 0.250 |
Why?
| | Mice | 20 | 2023 | 14916 | 0.250 |
Why?
| | Animals | 29 | 2023 | 31762 | 0.250 |
Why?
| | Eosinophilic Esophagitis | 2 | 2022 | 296 | 0.250 |
Why?
| | Colitis, Ulcerative | 2 | 2020 | 105 | 0.240 |
Why?
| | Bacteremia | 2 | 2018 | 159 | 0.240 |
Why?
| | Drug Resistance | 2 | 2017 | 158 | 0.240 |
Why?
| | Liver | 3 | 2020 | 1631 | 0.240 |
Why?
| | Metagenomics | 3 | 2019 | 131 | 0.240 |
Why?
| | High-Throughput Nucleotide Sequencing | 7 | 2017 | 440 | 0.240 |
Why?
| | Construction Materials | 2 | 2015 | 13 | 0.240 |
Why?
| | Staphylococcus aureus | 4 | 2021 | 385 | 0.240 |
Why?
| | Diabetes Mellitus, Type 1 | 6 | 2017 | 3248 | 0.240 |
Why?
| | Ecosystem | 2 | 2007 | 515 | 0.240 |
Why?
| | Adult | 28 | 2022 | 30548 | 0.230 |
Why?
| | Sputum | 5 | 2020 | 285 | 0.230 |
Why?
| | Infant Formula | 2 | 2023 | 74 | 0.220 |
Why?
| | Child | 21 | 2023 | 18352 | 0.220 |
Why?
| | Adrenal Cortex Hormones | 3 | 2017 | 498 | 0.220 |
Why?
| | Mice, Inbred C57BL | 12 | 2022 | 4710 | 0.220 |
Why?
| | Premature Birth | 3 | 2017 | 276 | 0.220 |
Why?
| | Diet, Western | 2 | 2022 | 66 | 0.220 |
Why?
| | Respiratory System | 2 | 2016 | 137 | 0.220 |
Why?
| | Anti-Bacterial Agents | 8 | 2023 | 1477 | 0.220 |
Why?
| | Milk, Human | 3 | 2023 | 128 | 0.220 |
Why?
| | Imaging, Three-Dimensional | 1 | 2007 | 513 | 0.220 |
Why?
| | Iron | 2 | 2016 | 234 | 0.210 |
Why?
| | Arthritis, Rheumatoid | 2 | 2023 | 1002 | 0.210 |
Why?
| | Inflammatory Bowel Diseases | 3 | 2018 | 283 | 0.210 |
Why?
| | Bile Acids and Salts | 2 | 2022 | 172 | 0.210 |
Why?
| | HIV Infections | 3 | 2022 | 2469 | 0.210 |
Why?
| | Gastrointestinal Tract | 3 | 2015 | 169 | 0.200 |
Why?
| | Staphylococcus | 4 | 2017 | 69 | 0.200 |
Why?
| | Otitis Media, Suppurative | 1 | 2022 | 4 | 0.200 |
Why?
| | Transcriptome | 3 | 2021 | 727 | 0.200 |
Why?
| | Cholesteatoma | 1 | 2022 | 11 | 0.200 |
Why?
| | Haemophilus Infections | 1 | 2022 | 28 | 0.200 |
Why?
| | Cross-Sectional Studies | 11 | 2021 | 4409 | 0.190 |
Why?
| | Anti-Asthmatic Agents | 2 | 2017 | 349 | 0.190 |
Why?
| | Staphylococcal Infections | 3 | 2015 | 336 | 0.190 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2012 | 162 | 0.190 |
Why?
| | Respiratory Tract Infections | 2 | 2023 | 319 | 0.180 |
Why?
| | Toxins, Biological | 1 | 2020 | 11 | 0.180 |
Why?
| | Colitis | 2 | 2020 | 223 | 0.180 |
Why?
| | Adolescent | 18 | 2021 | 17808 | 0.180 |
Why?
| | Ear, Middle | 4 | 2023 | 89 | 0.180 |
Why?
| | Pneumonia, Ventilator-Associated | 1 | 2021 | 40 | 0.180 |
Why?
| | Serine Peptidase Inhibitor Kazal-Type 5 | 1 | 2020 | 3 | 0.180 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 45 | 0.180 |
Why?
| | Groundwater | 1 | 2020 | 33 | 0.180 |
Why?
| | Perilipin-2 | 2 | 2017 | 36 | 0.180 |
Why?
| | Mucin 5AC | 1 | 2020 | 48 | 0.180 |
Why?
| | Nasal Polyps | 1 | 2020 | 49 | 0.180 |
Why?
| | Birth Weight | 2 | 2020 | 440 | 0.180 |
Why?
| | Sevelamer | 1 | 2020 | 9 | 0.170 |
Why?
| | Biofilms | 3 | 2017 | 223 | 0.170 |
Why?
| | Hot Springs | 2 | 2012 | 7 | 0.170 |
Why?
| | Tobacco Smoke Pollution | 1 | 2023 | 217 | 0.170 |
Why?
| | Pore Forming Cytotoxic Proteins | 1 | 2020 | 15 | 0.170 |
Why?
| | Burns | 1 | 2023 | 237 | 0.170 |
Why?
| | Middle Aged | 20 | 2021 | 26757 | 0.170 |
Why?
| | Bronchopulmonary Dysplasia | 2 | 2017 | 331 | 0.170 |
Why?
| | RNA, Ribosomal | 4 | 2013 | 157 | 0.170 |
Why?
| | Body Mass Index | 4 | 2020 | 1958 | 0.170 |
Why?
| | Respiratory System Agents | 1 | 2020 | 22 | 0.170 |
Why?
| | Inflammation Mediators | 2 | 2020 | 476 | 0.170 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 122 | 0.170 |
Why?
| | Polymerase Chain Reaction | 7 | 2017 | 994 | 0.170 |
Why?
| | Bacteroides | 1 | 2019 | 16 | 0.160 |
Why?
| | Corrinoids | 1 | 2019 | 7 | 0.160 |
Why?
| | Infant | 10 | 2023 | 7935 | 0.160 |
Why?
| | Chronic Disease | 7 | 2022 | 1590 | 0.160 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2020 | 141 | 0.160 |
Why?
| | Esomeprazole | 1 | 2018 | 6 | 0.160 |
Why?
| | Vitamin B Complex | 1 | 2019 | 38 | 0.160 |
Why?
| | Diet, High-Fat | 2 | 2017 | 225 | 0.160 |
Why?
| | Oxonic Acid | 1 | 2018 | 3 | 0.160 |
Why?
| | Intubation, Intratracheal | 2 | 2017 | 215 | 0.160 |
Why?
| | Quinolones | 1 | 2020 | 97 | 0.160 |
Why?
| | Aminophenols | 1 | 2020 | 112 | 0.160 |
Why?
| | Intraepithelial Lymphocytes | 1 | 2018 | 12 | 0.150 |
Why?
| | Alphaproteobacteria | 2 | 2016 | 8 | 0.150 |
Why?
| | Hyperuricemia | 1 | 2018 | 44 | 0.150 |
Why?
| | Vitamin B 12 | 1 | 2019 | 115 | 0.150 |
Why?
| | Down Syndrome | 1 | 2023 | 338 | 0.150 |
Why?
| | Asthma | 3 | 2017 | 2032 | 0.150 |
Why?
| | Corrosion | 2 | 2015 | 15 | 0.150 |
Why?
| | Chloramines | 2 | 2015 | 11 | 0.150 |
Why?
| | Hydraulic Fracking | 1 | 2018 | 15 | 0.150 |
Why?
| | Probiotics | 1 | 2018 | 46 | 0.150 |
Why?
| | Immunity, Innate | 3 | 2019 | 723 | 0.150 |
Why?
| | Spondylarthritis | 1 | 2018 | 36 | 0.150 |
Why?
| | Disease Models, Animal | 7 | 2022 | 3542 | 0.150 |
Why?
| | Dacryocystorhinostomy | 1 | 2017 | 10 | 0.150 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 436 | 0.140 |
Why?
| | Young Adult | 11 | 2021 | 10463 | 0.140 |
Why?
| | Sequence Analysis, RNA | 3 | 2020 | 388 | 0.140 |
Why?
| | Sepsis | 1 | 2023 | 508 | 0.140 |
Why?
| | Infant Nutritional Physiological Phenomena | 2 | 2023 | 133 | 0.140 |
Why?
| | Clostridium Infections | 1 | 2018 | 56 | 0.140 |
Why?
| | Respiration, Artificial | 3 | 2023 | 526 | 0.140 |
Why?
| | Biomarkers | 5 | 2020 | 3416 | 0.140 |
Why?
| | Parvovirus | 2 | 2017 | 13 | 0.140 |
Why?
| | Metabolic Syndrome | 1 | 2020 | 323 | 0.140 |
Why?
| | Diabetes, Gestational | 1 | 2020 | 281 | 0.140 |
Why?
| | Lipid Metabolism | 2 | 2020 | 446 | 0.140 |
Why?
| | Pharynx | 1 | 2016 | 50 | 0.130 |
Why?
| | Vitamin E | 1 | 2016 | 110 | 0.130 |
Why?
| | Rivers | 1 | 2016 | 54 | 0.130 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2015 | 16 | 0.130 |
Why?
| | Therapeutic Irrigation | 1 | 2016 | 67 | 0.130 |
Why?
| | Prospective Studies | 7 | 2022 | 6217 | 0.130 |
Why?
| | Ethmoid Sinus | 1 | 2015 | 7 | 0.130 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2016 | 53 | 0.130 |
Why?
| | Textiles | 1 | 2015 | 19 | 0.130 |
Why?
| | Delivery, Obstetric | 1 | 2016 | 119 | 0.130 |
Why?
| | Dietary Fats | 1 | 2017 | 287 | 0.130 |
Why?
| | Infant, Newborn | 7 | 2023 | 5035 | 0.130 |
Why?
| | Child, Preschool | 8 | 2023 | 9079 | 0.130 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2020 | 486 | 0.130 |
Why?
| | Lactobacillus | 3 | 2022 | 24 | 0.130 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2015 | 18 | 0.130 |
Why?
| | Base Sequence | 3 | 2015 | 2118 | 0.120 |
Why?
| | Nose | 1 | 2015 | 55 | 0.120 |
Why?
| | Sanitary Engineering | 1 | 2015 | 6 | 0.120 |
Why?
| | Bronchi | 1 | 2016 | 232 | 0.120 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2015 | 32 | 0.120 |
Why?
| | Health Facilities | 1 | 2015 | 72 | 0.120 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2020 | 452 | 0.120 |
Why?
| | Vaccines, Conjugate | 1 | 2015 | 60 | 0.120 |
Why?
| | Bacteriology | 1 | 2014 | 3 | 0.120 |
Why?
| | Rats | 6 | 2023 | 4943 | 0.120 |
Why?
| | Biota | 1 | 2015 | 35 | 0.120 |
Why?
| | Aged | 11 | 2023 | 19094 | 0.120 |
Why?
| | Oropharynx | 1 | 2015 | 36 | 0.120 |
Why?
| | Humidity | 1 | 2014 | 37 | 0.120 |
Why?
| | Leptin | 1 | 2016 | 211 | 0.120 |
Why?
| | Household Articles | 1 | 2014 | 23 | 0.120 |
Why?
| | Antibiotic Prophylaxis | 1 | 2015 | 96 | 0.120 |
Why?
| | Siblings | 1 | 2015 | 222 | 0.120 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 621 | 0.120 |
Why?
| | Hippocampus | 1 | 2018 | 695 | 0.120 |
Why?
| | Computational Biology | 2 | 2019 | 530 | 0.110 |
Why?
| | Age Factors | 2 | 2019 | 2890 | 0.110 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2014 | 58 | 0.110 |
Why?
| | Hydrogen Sulfide | 1 | 2014 | 40 | 0.110 |
Why?
| | Pneumococcal Vaccines | 1 | 2015 | 132 | 0.110 |
Why?
| | Toll-Like Receptor 3 | 1 | 2013 | 26 | 0.110 |
Why?
| | Cecum | 3 | 2020 | 32 | 0.110 |
Why?
| | Gram-Positive Bacteria | 1 | 2013 | 45 | 0.110 |
Why?
| | Parenteral Nutrition | 1 | 2014 | 96 | 0.110 |
Why?
| | Nasal Cavity | 1 | 2013 | 47 | 0.110 |
Why?
| | Genetic Variation | 1 | 2018 | 876 | 0.110 |
Why?
| | Pediatric Obesity | 1 | 2020 | 489 | 0.110 |
Why?
| | Soil Microbiology | 1 | 2015 | 177 | 0.110 |
Why?
| | Cities | 1 | 2013 | 80 | 0.110 |
Why?
| | DNA, Ribosomal | 2 | 2015 | 79 | 0.110 |
Why?
| | Saliva | 1 | 2015 | 189 | 0.110 |
Why?
| | Autoantibodies | 2 | 2018 | 1350 | 0.110 |
Why?
| | Membrane Proteins | 2 | 2019 | 1022 | 0.110 |
Why?
| | Bacteroidetes | 3 | 2021 | 20 | 0.110 |
Why?
| | HIV-1 | 1 | 2019 | 768 | 0.110 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2013 | 90 | 0.110 |
Why?
| | New York City | 1 | 2013 | 70 | 0.110 |
Why?
| | Gastric Bypass | 1 | 2014 | 92 | 0.110 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 191 | 0.110 |
Why?
| | Iron, Dietary | 1 | 2013 | 19 | 0.110 |
Why?
| | Prednisone | 1 | 2013 | 231 | 0.100 |
Why?
| | Antioxidants | 1 | 2016 | 530 | 0.100 |
Why?
| | Carbon Dioxide | 1 | 2014 | 218 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2021 | 316 | 0.100 |
Why?
| | Bacterial Infections | 1 | 2014 | 219 | 0.100 |
Why?
| | Infant Food | 1 | 2013 | 63 | 0.100 |
Why?
| | Gastroesophageal Reflux | 1 | 2015 | 234 | 0.100 |
Why?
| | Seawater | 1 | 2012 | 20 | 0.100 |
Why?
| | Mexico | 2 | 2012 | 162 | 0.100 |
Why?
| | Anti-Infective Agents | 1 | 2015 | 225 | 0.100 |
Why?
| | Paneth Cells | 1 | 2012 | 17 | 0.100 |
Why?
| | Xenobiotics | 1 | 2012 | 24 | 0.100 |
Why?
| | Body Fluids | 1 | 2012 | 58 | 0.100 |
Why?
| | Bacterial Translocation | 1 | 2012 | 36 | 0.100 |
Why?
| | Islets of Langerhans | 2 | 2015 | 728 | 0.100 |
Why?
| | Kidney | 1 | 2018 | 1184 | 0.100 |
Why?
| | Gonadal Steroid Hormones | 1 | 2013 | 124 | 0.100 |
Why?
| | Mice, Knockout | 4 | 2022 | 2582 | 0.100 |
Why?
| | Obesity, Morbid | 1 | 2014 | 197 | 0.090 |
Why?
| | Sequence Analysis | 1 | 2011 | 35 | 0.090 |
Why?
| | Cytokines | 2 | 2018 | 1843 | 0.090 |
Why?
| | Stress, Psychological | 1 | 2018 | 944 | 0.090 |
Why?
| | Autism Spectrum Disorder | 1 | 2015 | 323 | 0.090 |
Why?
| | Obesity | 2 | 2021 | 2513 | 0.090 |
Why?
| | Autoimmunity | 2 | 2015 | 814 | 0.090 |
Why?
| | Indoles | 1 | 2013 | 306 | 0.090 |
Why?
| | Phenotype | 5 | 2020 | 2812 | 0.090 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 364 | 0.090 |
Why?
| | Esophagus | 1 | 2012 | 226 | 0.090 |
Why?
| | Cohort Studies | 5 | 2019 | 4901 | 0.090 |
Why?
| | Genes, Bacterial | 3 | 2018 | 157 | 0.090 |
Why?
| | Weight Loss | 1 | 2014 | 642 | 0.080 |
Why?
| | Dextran Sulfate | 2 | 2020 | 70 | 0.080 |
Why?
| | Genotype | 4 | 2019 | 1774 | 0.080 |
Why?
| | Pseudomonas aeruginosa | 2 | 2023 | 298 | 0.080 |
Why?
| | Cholesterol | 2 | 2022 | 368 | 0.080 |
Why?
| | Pregnancy | 5 | 2020 | 5525 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2097 | 0.080 |
Why?
| | Pacific Ocean | 1 | 2008 | 5 | 0.080 |
Why?
| | RNA, Archaeal | 1 | 2008 | 13 | 0.080 |
Why?
| | DNA, Archaeal | 1 | 2008 | 16 | 0.080 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2008 | 152 | 0.080 |
Why?
| | Firmicutes | 2 | 2021 | 17 | 0.080 |
Why?
| | Exome | 2 | 2020 | 200 | 0.080 |
Why?
| | Pedigree | 2 | 2020 | 464 | 0.080 |
Why?
| | Sex Characteristics | 1 | 2013 | 640 | 0.080 |
Why?
| | Smoke | 2 | 2023 | 123 | 0.080 |
Why?
| | Methane | 2 | 2020 | 41 | 0.070 |
Why?
| | Fatty Acids | 2 | 2022 | 382 | 0.070 |
Why?
| | Bacterial Load | 2 | 2021 | 58 | 0.070 |
Why?
| | Models, Statistical | 1 | 2011 | 604 | 0.070 |
Why?
| | Cryoprotective Agents | 1 | 2007 | 10 | 0.070 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 916 | 0.070 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2007 | 57 | 0.070 |
Why?
| | Freezing | 1 | 2007 | 85 | 0.070 |
Why?
| | Equipment Contamination | 2 | 2017 | 54 | 0.070 |
Why?
| | Gammaproteobacteria | 2 | 2016 | 14 | 0.070 |
Why?
| | Insulin | 1 | 2016 | 2079 | 0.070 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 928 | 0.070 |
Why?
| | Carrier Proteins | 1 | 2010 | 696 | 0.070 |
Why?
| | Disease Susceptibility | 2 | 2020 | 316 | 0.070 |
Why?
| | Genes, Archaeal | 1 | 2005 | 6 | 0.070 |
Why?
| | Cryopreservation | 1 | 2007 | 92 | 0.060 |
Why?
| | Diabetes Mellitus | 1 | 2013 | 904 | 0.060 |
Why?
| | Principal Component Analysis | 2 | 2017 | 176 | 0.060 |
Why?
| | Treatment Outcome | 5 | 2020 | 9089 | 0.060 |
Why?
| | Rats, Inbred Lew | 2 | 2017 | 92 | 0.060 |
Why?
| | Body Composition | 2 | 2021 | 592 | 0.060 |
Why?
| | Water Purification | 2 | 2017 | 128 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2321 | 0.060 |
Why?
| | Aged, 80 and over | 3 | 2021 | 6350 | 0.060 |
Why?
| | Gestational Age | 2 | 2017 | 759 | 0.060 |
Why?
| | Disinfection | 2 | 2017 | 106 | 0.060 |
Why?
| | Neoplasms | 1 | 2018 | 2105 | 0.060 |
Why?
| | RNA, Messenger | 3 | 2018 | 2557 | 0.060 |
Why?
| | Administration, Oral | 2 | 2019 | 731 | 0.060 |
Why?
| | Colorado | 3 | 2020 | 4086 | 0.060 |
Why?
| | Tobramycin | 1 | 2023 | 47 | 0.060 |
Why?
| | Geography | 2 | 2014 | 180 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2015 | 511 | 0.050 |
Why?
| | Interleukin-17 | 1 | 2023 | 104 | 0.050 |
Why?
| | Multivariate Analysis | 2 | 2017 | 1435 | 0.050 |
Why?
| | Azithromycin | 1 | 2023 | 80 | 0.050 |
Why?
| | Neutrophils | 2 | 2021 | 1163 | 0.050 |
Why?
| | Animal Husbandry | 1 | 2023 | 33 | 0.050 |
Why?
| | Ammonia | 1 | 2023 | 56 | 0.050 |
Why?
| | Brain | 1 | 2014 | 2374 | 0.050 |
Why?
| | Sanitation | 1 | 2023 | 50 | 0.050 |
Why?
| | Tryptophan | 1 | 2023 | 135 | 0.050 |
Why?
| | Linear Models | 2 | 2016 | 770 | 0.050 |
Why?
| | Housing, Animal | 1 | 2023 | 43 | 0.050 |
Why?
| | Flow Cytometry | 2 | 2017 | 1086 | 0.050 |
Why?
| | Cotinine | 1 | 2023 | 69 | 0.050 |
Why?
| | Water | 2 | 2018 | 399 | 0.050 |
Why?
| | Chemokines | 1 | 2023 | 213 | 0.050 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2386 | 0.050 |
Why?
| | Virulence | 1 | 2023 | 227 | 0.050 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2022 | 8 | 0.050 |
Why?
| | Haemophilus influenzae | 1 | 2022 | 48 | 0.050 |
Why?
| | Administration, Inhalation | 1 | 2023 | 642 | 0.050 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2022 | 39 | 0.050 |
Why?
| | Endoscopy | 2 | 2015 | 248 | 0.050 |
Why?
| | Collagen | 1 | 2023 | 415 | 0.050 |
Why?
| | Multigene Family | 2 | 2012 | 193 | 0.050 |
Why?
| | Ligands | 1 | 2023 | 565 | 0.050 |
Why?
| | Predictive Value of Tests | 2 | 2018 | 1796 | 0.050 |
Why?
| | Bacterial Proteins | 2 | 2018 | 739 | 0.050 |
Why?
| | Aerobiosis | 1 | 2020 | 20 | 0.050 |
Why?
| | Smoking | 2 | 2020 | 1384 | 0.050 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2022 | 193 | 0.050 |
Why?
| | Hospitals | 2 | 2015 | 580 | 0.050 |
Why?
| | Mice, Inbred NOD | 2 | 2013 | 561 | 0.050 |
Why?
| | Drug Administration Schedule | 2 | 2013 | 718 | 0.040 |
Why?
| | Oil and Gas Fields | 1 | 2020 | 32 | 0.040 |
Why?
| | Ear, External | 1 | 2020 | 24 | 0.040 |
Why?
| | Carcinogenesis | 1 | 2022 | 180 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 453 | 0.040 |
Why?
| | Protective Factors | 1 | 2020 | 87 | 0.040 |
Why?
| | Mouth | 1 | 2020 | 69 | 0.040 |
Why?
| | Cell Line | 2 | 2018 | 2639 | 0.040 |
Why?
| | Diet | 2 | 2019 | 1080 | 0.040 |
Why?
| | Sweat | 1 | 2020 | 38 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 105 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2021 | 343 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 108 | 0.040 |
Why?
| | X-Box Binding Protein 1 | 1 | 2019 | 7 | 0.040 |
Why?
| | Risk Factors | 3 | 2017 | 8627 | 0.040 |
Why?
| | Environmental Monitoring | 1 | 2020 | 254 | 0.040 |
Why?
| | Restraint, Physical | 1 | 2018 | 67 | 0.040 |
Why?
| | Cytoprotection | 1 | 2018 | 51 | 0.040 |
Why?
| | Forced Expiratory Volume | 1 | 2020 | 476 | 0.040 |
Why?
| | Prognosis | 2 | 2020 | 3334 | 0.040 |
Why?
| | COS Cells | 1 | 2018 | 175 | 0.040 |
Why?
| | Collagen Type II | 1 | 2018 | 48 | 0.040 |
Why?
| | Digestive System Surgical Procedures | 1 | 2019 | 90 | 0.040 |
Why?
| | HIV Seropositivity | 1 | 2019 | 109 | 0.040 |
Why?
| | Random Allocation | 1 | 2018 | 335 | 0.040 |
Why?
| | Critical Illness | 1 | 2023 | 643 | 0.040 |
Why?
| | Fetal Membranes, Premature Rupture | 1 | 2017 | 34 | 0.040 |
Why?
| | Immunity, Mucosal | 1 | 2018 | 84 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2018 | 368 | 0.040 |
Why?
| | Chorioamnionitis | 1 | 2017 | 36 | 0.040 |
Why?
| | New Orleans | 1 | 2017 | 14 | 0.040 |
Why?
| | Pancrelipase | 1 | 2017 | 6 | 0.040 |
Why?
| | Uric Acid | 1 | 2018 | 148 | 0.040 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2017 | 66 | 0.040 |
Why?
| | Bacterial Toxins | 1 | 2018 | 103 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2020 | 449 | 0.040 |
Why?
| | Infant, Extremely Premature | 1 | 2017 | 57 | 0.040 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1151 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 2 | 2021 | 3039 | 0.040 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2017 | 192 | 0.030 |
Why?
| | Homeostasis | 1 | 2020 | 575 | 0.030 |
Why?
| | Hydroxamic Acids | 1 | 2017 | 80 | 0.030 |
Why?
| | Water Supply | 1 | 2017 | 70 | 0.030 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2020 | 287 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2021 | 618 | 0.030 |
Why?
| | Betaproteobacteria | 1 | 2016 | 6 | 0.030 |
Why?
| | Lactobacillales | 1 | 2016 | 6 | 0.030 |
Why?
| | Ferritins | 1 | 2016 | 52 | 0.030 |
Why?
| | Metabolic Networks and Pathways | 1 | 2017 | 168 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 594 | 0.030 |
Why?
| | Pyruvate Kinase | 1 | 2016 | 20 | 0.030 |
Why?
| | Ohio | 1 | 2016 | 135 | 0.030 |
Why?
| | Bacillus | 1 | 2015 | 14 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 104 | 0.030 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2017 | 253 | 0.030 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 612 | 0.030 |
Why?
| | Antibiosis | 1 | 2015 | 7 | 0.030 |
Why?
| | Streptococcus mitis | 1 | 2015 | 8 | 0.030 |
Why?
| | Pre-Eclampsia | 1 | 2017 | 165 | 0.030 |
Why?
| | Rectum | 1 | 2016 | 153 | 0.030 |
Why?
| | Catalase | 1 | 2015 | 117 | 0.030 |
Why?
| | Capsule Endoscopes | 1 | 2015 | 7 | 0.030 |
Why?
| | Spleen | 1 | 2017 | 484 | 0.030 |
Why?
| | Regression Analysis | 1 | 2017 | 946 | 0.030 |
Why?
| | Diet, Fat-Restricted | 1 | 2015 | 73 | 0.030 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2015 | 29 | 0.030 |
Why?
| | Pseudomonas | 1 | 2015 | 26 | 0.030 |
Why?
| | Carrier State | 1 | 2015 | 54 | 0.030 |
Why?
| | Kenya | 1 | 2015 | 97 | 0.030 |
Why?
| | Pennsylvania | 1 | 2015 | 94 | 0.030 |
Why?
| | Enterobacteriaceae | 1 | 2015 | 32 | 0.030 |
Why?
| | Corynebacterium | 1 | 2015 | 36 | 0.030 |
Why?
| | Vagina | 1 | 2016 | 146 | 0.030 |
Why?
| | DNA | 2 | 2014 | 1351 | 0.030 |
Why?
| | Molecular Typing | 1 | 2014 | 18 | 0.030 |
Why?
| | Verrucomicrobia | 1 | 2014 | 5 | 0.030 |
Why?
| | Plant Oils | 1 | 2014 | 26 | 0.030 |
Why?
| | Proteobacteria | 1 | 2014 | 16 | 0.030 |
Why?
| | Enterobacteriaceae Infections | 1 | 2015 | 32 | 0.030 |
Why?
| | Permeability | 1 | 2015 | 148 | 0.030 |
Why?
| | Bronchoalveolar Lavage | 1 | 2014 | 84 | 0.030 |
Why?
| | Kupffer Cells | 1 | 2014 | 45 | 0.030 |
Why?
| | Colony Count, Microbial | 1 | 2014 | 111 | 0.030 |
Why?
| | Physical Exertion | 1 | 2015 | 211 | 0.030 |
Why?
| | Spirometry | 1 | 2015 | 225 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2017 | 423 | 0.030 |
Why?
| | Perioperative Care | 1 | 2015 | 126 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 1846 | 0.030 |
Why?
| | Porosity | 1 | 2014 | 89 | 0.030 |
Why?
| | Streptococcus pneumoniae | 1 | 2015 | 134 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2012 | 1892 | 0.030 |
Why?
| | Poly I-C | 1 | 2013 | 51 | 0.030 |
Why?
| | Pilot Projects | 1 | 2018 | 1370 | 0.030 |
Why?
| | Toll-Like Receptor 9 | 1 | 2013 | 30 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2015 | 460 | 0.030 |
Why?
| | Observer Variation | 1 | 2014 | 295 | 0.030 |
Why?
| | Connectome | 1 | 2014 | 63 | 0.030 |
Why?
| | Gene Expression | 1 | 2018 | 1420 | 0.030 |
Why?
| | Nitrates | 1 | 2013 | 71 | 0.030 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 133 | 0.030 |
Why?
| | Cell Separation | 1 | 2014 | 292 | 0.030 |
Why?
| | Seasons | 1 | 2015 | 450 | 0.030 |
Why?
| | Hot Temperature | 1 | 2015 | 304 | 0.030 |
Why?
| | Aging | 1 | 2023 | 1620 | 0.030 |
Why?
| | Infant, Premature | 1 | 2017 | 478 | 0.030 |
Why?
| | Liver Cirrhosis | 1 | 2015 | 228 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2013 | 396 | 0.030 |
Why?
| | Trimethoprim | 1 | 2012 | 6 | 0.030 |
Why?
| | Sulfadoxine | 1 | 2012 | 4 | 0.030 |
Why?
| | Sulfamethoxazole | 1 | 2012 | 6 | 0.030 |
Why?
| | Peyer's Patches | 1 | 2012 | 7 | 0.030 |
Why?
| | Surgical Wound Infection | 1 | 2015 | 248 | 0.030 |
Why?
| | DNA, Viral | 1 | 2014 | 350 | 0.030 |
Why?
| | Neural Pathways | 1 | 2014 | 261 | 0.030 |
Why?
| | Expressed Sequence Tags | 1 | 2012 | 38 | 0.030 |
Why?
| | Genetic Markers | 1 | 2013 | 321 | 0.030 |
Why?
| | Rats, Inbred Strains | 1 | 2012 | 354 | 0.030 |
Why?
| | Lubiprostone | 1 | 2012 | 9 | 0.030 |
Why?
| | Ribosome Subunits, Small, Eukaryotic | 1 | 2012 | 8 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2539 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2018 | 1084 | 0.030 |
Why?
| | Phototrophic Processes | 1 | 2012 | 1 | 0.030 |
Why?
| | Alprostadil | 1 | 2012 | 32 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2016 | 1662 | 0.030 |
Why?
| | Protein Interaction Maps | 1 | 2012 | 34 | 0.030 |
Why?
| | Electrolytes | 1 | 2012 | 55 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2020 | 2099 | 0.020 |
Why?
| | Skin | 1 | 2016 | 659 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2012 | 81 | 0.020 |
Why?
| | Blood Glucose | 1 | 2021 | 1821 | 0.020 |
Why?
| | Chlorine | 1 | 2012 | 62 | 0.020 |
Why?
| | Genome, Bacterial | 1 | 2012 | 106 | 0.020 |
Why?
| | Chloride Channel Agonists | 1 | 2012 | 62 | 0.020 |
Why?
| | Cyanobacteria | 1 | 2012 | 54 | 0.020 |
Why?
| | Drug Combinations | 1 | 2012 | 286 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2015 | 450 | 0.020 |
Why?
| | Suction | 1 | 2011 | 31 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2020 | 4420 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 2013 | 524 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2017 | 955 | 0.020 |
Why?
| | Body Weight | 1 | 2015 | 869 | 0.020 |
Why?
| | Databases, Genetic | 1 | 2012 | 206 | 0.020 |
Why?
| | Disease Progression | 1 | 2017 | 2387 | 0.020 |
Why?
| | Adiposity | 1 | 2015 | 457 | 0.020 |
Why?
| | Nutritional Status | 1 | 2013 | 286 | 0.020 |
Why?
| | Escherichia coli Proteins | 1 | 2012 | 162 | 0.020 |
Why?
| | Equipment Design | 1 | 2012 | 508 | 0.020 |
Why?
| | Macrophages, Alveolar | 1 | 2013 | 347 | 0.020 |
Why?
| | Autophagy-Related Proteins | 1 | 2010 | 39 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2012 | 228 | 0.020 |
Why?
| | Laparoscopy | 1 | 2014 | 388 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2012 | 743 | 0.020 |
Why?
| | Models, Genetic | 1 | 2012 | 565 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 3890 | 0.020 |
Why?
| | Mutation | 1 | 2020 | 3350 | 0.020 |
Why?
| | Risk | 1 | 2011 | 815 | 0.020 |
Why?
| | Biopsy | 1 | 2012 | 1040 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2015 | 1521 | 0.020 |
Why?
| | Escherichia coli | 1 | 2012 | 722 | 0.020 |
Why?
| | Thermus | 1 | 2007 | 1 | 0.020 |
Why?
| | Macrophages | 1 | 2014 | 1261 | 0.020 |
Why?
| | Mining | 1 | 2007 | 16 | 0.020 |
Why?
| | Chloroflexi | 1 | 2007 | 12 | 0.020 |
Why?
| | Vaccination | 1 | 2015 | 1205 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 849 | 0.020 |
Why?
| | Hospitalization | 1 | 2015 | 1752 | 0.020 |
Why?
| | Temperature | 1 | 2007 | 575 | 0.010 |
Why?
| | United States | 1 | 2015 | 12176 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2012 | 12515 | 0.010 |
Why?
|
|
Robertson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|